PepGen
pepgen.com
Actively hiring
Information Technology
Biotechnology
Health Care
As featured in
View 2 jobs
Claim pageClaim
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
News
PepGen Advances PGN-EDODM1 Trial and Strengthens Finances
Detailed price information for Pepgen Inc (PEPG-Q) from The Globe and Mail including charting and trades.
Read more
Report
PepGen (PEPG) Loses 14.3% in 4 Weeks, Here
PepGen (PEPG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Read more
Report
PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
BOSTON,, September 26, 2025--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company developing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, toda
Read more
Report
Faruqi & Faruqi Reminds PepGen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - PEPG
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against PepGen Inc. ("PepGen" or the "Company")...
Read more
Report
PEPG Investors Have the Opportunity to Lead the PepGen Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against PepGen Inc. ("PepGen" or the "Company")...
Read more
Report
PepGen Drug Shows Signs of Topping Rivals in Rare Muscle Disease With No Approved Meds
PepGen is one of several companies vying to bring to market the first treatment for the rare muscle disorder myotonic dystrophy type 1, or DM1. Preliminary Phase 1 data indicate its drug candidate is competitive with others further ahead in development.
Read more
Report
PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development
Read more
Report
PepGen IPO nabs $108M for muscular dystrophy drug with potential edge over Sarepta med
PepGen's technology improves the delivery of a therapy to more tissue types and the clinical-stage biotech plans to use its IPO cash to continue developing its lead program for Duchenne muscular dystrophy. Meanwhile, eye products giant Bausch + Lomb retur
Read more
Report
Tech stack
Technologies named in job postings at PepGen over the last 12 months, by layer, with the share of postings for each.
Technologies in use
5
Postings analysed
2
Stack modernity
55/100
Practices & domains
Chromatography
GMP
HPLC
Mass Spectrometry
GLP
Sign in to see how your skills match this stack
Sign In
Salary insights
Compensation ranges based on this company's open jobs
Median
$183k
Typical range
$146k – $220k
Open positions
2
2
Jobs
Middle
50%
Architect
50%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Middle | 1 | $146k | $146k |
| Architect | 1 | $220k | $220k |
Highest paying role
Associate Director, Analytical Development
$220k
Normalized to USD per year
People
Caroline Godfrey
Executive Officer, Director
James McArthur
Executive Officer, Director
Matthew Wood
Director
Josh Resnick
Director
Ramin Farzaneh-Far
Director
Christopher Ashton
Director
Joshua Resnick
Director
Heidi Henson
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
28/100
Slowing
Open positions
2
0 opened / 0 closed in 30 days
ATS activity
Every ~6 hours
10/22/2026
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Science & Research
50% ▲
Biotech
50% ▲
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Boston
Boston
United States
HQ
1 open roles 1 posted in 90 days 100% engineering $146k Avg Salary
hires for Science & Research
Jobs
$170k – $220k per year • In office • 8+ years exp • Master's Degree
Mass Spectrometry
HPLC
Chromatography
GMP
Apply
$128k – $146k per year • In office • 1+ year exp • PhD • Boston
Mass Spectrometry
HPLC
Chromatography
GMP
GLP
Apply